Abstract P2-04-27: Development & Validation of RSC4All: an Artificial Intelligence-driven Machine Learning Nomogram Enhanced with Synthetic Data to Predict RSClin® Results & Guide Adjuvant Treatment of Node-negative HR-positive/HER2-negative Early Breast CancerFlavia Jacobs, Alberto Zambelli, Emanuela Ferraro et al.|Clinical Cancer Research|2025Cited by 0